DAKT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient buyer: price is extended/overbought (RSI-6 ~89.6) and trading near first resistance (R1 ~24.34), which raises near-term pullback risk.", "Trend is bullish (SMA_5 > SMA_20 > SMA_200 and MACD histogram expanding), so this is not a bearish setup\u2014just a poor entry timing at current levels.", "Insider selling has surged recently (+745.8% last month), which is a meaningful near-term negative against the otherwise supportive hedge-fund buying (+219.96% QoQ).", "With earnings on 2026-02-27 (pre-market), an impatient entry now is exposed to event risk while options imply elevated uncertainty (30D IV ~69%)."]
["Trend: Bullish structure with moving averages aligned (SMA_5 > SMA_20 > SMA_200), indicating an established uptrend.", "Momentum: MACD histogram at 0.217 and expanding above zero = bullish momentum still building.", "Overbought: RSI_6 at ~89.56 signals the move is stretched; odds favor consolidation/pullback rather than clean upside continuation immediately.", "Levels: Pivot ~22.89 as a key reference; near-term resistance R1 ~24.34 (very close to current 24.16) then R2 ~25.24; supports S1 ~21.45 and S2 ~20.55.", "Pattern-based expectation: Similar-pattern stats suggest slight weakness next day/week (-0.22% / -0.18%) but modest upside over the next month (+2.73%), consistent with 'uptrend but overheated entry'."]
["Hedge funds are net buyers (buying amount +219.96% over the last quarter), supportive for demand/price trend.", "Technicals remain firmly bullish (MA alignment + positive, expanding MACD).", "Next earnings (2026-02-27 pre-market) could act as a catalyst if results/guide surprise to the upside."]
increases probability of near-term pullback or sideways consolidation.", "No positive news flow in the last week; momentum is running without fresh catalysts.", "Elevated implied volatility (30D IV ~69%) indicates the market is pricing significant event risk into the near-term window."]
["Latest quarter: 2026/Q2.", "Revenue: 229.253M, up +10.04% YoY (healthy top-line growth).", "Profitability: Net income 17.481M, down -18.34% YoY; EPS 0.35, down -14.63% YoY (margin/expense pressure despite revenue growth).", "Gross margin: 26.97%, up +0.60 YoY (slight improvement, but not enough to prevent EPS decline).", "Takeaway: Growth is solid on revenue, but earnings quality is mixed\u2014this supports a bullish longer trend but weakens the case for chasing at an overbought price."]
["No analyst rating/price target change data was provided, so a verified recent Wall Street trend cannot be summarized from the dataset.", "Wall Street-style pros (based on available fundamentals/price action): accelerating revenue growth and strong technical uptrend.", "Wall Street-style cons (based on available fundamentals/positioning): YoY decline in net income/EPS and heavy insider selling; elevated IV into upcoming earnings suggests uncertainty."]
